Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT04628338. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
ClinicalTrials.gov study NCT03987958. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Modified-FLAI Induction and Consolidation Chemotherapy in Elderly Patient With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01247493. IPD Sharing: Not stated. Countries: 1. Publications: 1.
NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00476541. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
ClinicalTrials.gov study NCT05453903. IPD Sharing: YES. Countries: 8. Publications: 1.
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL),
ClinicalTrials.gov study NCT05086315. IPD Sharing: YES. Countries: 5. Publications: 0.
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
ClinicalTrials.gov study NCT02632708. IPD Sharing: YES. Countries: 3. Publications: 4.
Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00079482. IPD Sharing: Not stated. Countries: 13. Publications: 1.
A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)
ClinicalTrials.gov study NCT03030612. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01382147. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00850382. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02864290. IPD Sharing: NO. Countries: 2. Publications: 1.
A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02249091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02003573. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04905407. IPD Sharing: NO. Countries: 2. Publications: 0.
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00778375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00480987. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of I
ClinicalTrials.gov study NCT03850535. IPD Sharing: NO. Countries: 5. Publications: 0.
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01468467. IPD Sharing: YES. Countries: 1. Publications: 0.
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04714372. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.